A review of available studies on Efavirenz has found no increased risk of overall birth defects among women exposed to the antiretroviral during the first trimester of pregnancy compared with exposure to other antiretroviral drugs. The results were published in the AIDS Journal and comes after the South African Government opted not to include the […]
About Health-e NewsHealth-e News is an award-winning print and TV health news service providing content to South African news outlets. It is also home to the OurHealth citizen journalism initiative. Read more.
Subscribe for weekly updatesGet the latest health news via email every week. Subscribe
Support usHelp sustain our work by making a donation. Find out more.